What is the recommended treatment for panic and anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Panic and Anxiety

The first-line treatment for anxiety disorders should be a combination of Cognitive Behavioral Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), with individual CBT specifically developed for anxiety disorders being preferred over group therapy due to superior clinical and economic effectiveness. 1

Psychotherapy Options

  • Cognitive Behavioral Therapy (CBT):
    • Highest level of evidence among psychotherapies for anxiety disorders 1
    • Helps patients understand and modify patterns that perpetuate anxiety
    • Teaches strategies to counter fears and break cycles of anticipatory anxiety and panic
    • Individual therapy is preferred over group therapy for better outcomes

Pharmacological Treatment

First-Line Medications:

  1. SSRIs (e.g., sertraline, escitalopram, paroxetine, fluoxetine):

    • Recommended by the American College of Physicians as first-line treatment 1
    • High efficacy, relatively safe side effect profile, low risk of dependence
    • For panic disorder, treatment should start with fluoxetine 10 mg/day, increasing to 20 mg/day after one week 2
    • Dosage can be increased if no clinical improvement is observed after several weeks
  2. SNRIs (e.g., venlafaxine, duloxetine):

    • Alternative first-line options 1
    • Duloxetine is the only SNRI with FDA indication specifically for generalized anxiety disorder
    • For social anxiety disorder, start venlafaxine at 20 mg once daily, titrating to 20-50 mg daily 1

Medication Management:

  • Assess treatment response after 4-6 weeks of medication
  • Continue effective medication for at least 6-12 months after symptom remission
  • Taper gradually when discontinuing to avoid withdrawal symptoms 1
  • Lower or less frequent dosing should be considered for:
    • Elderly patients
    • Patients with hepatic impairment
    • Patients with concurrent diseases or on multiple medications 2

Treatment Algorithm

  1. Initial Treatment:

    • Start with individual CBT specifically developed for anxiety disorders
    • Simultaneously initiate an SSRI (e.g., fluoxetine 10-20 mg/day) or SNRI
    • For severe symptoms causing significant impairment, prioritize medication for rapid relief
  2. Assessment and Adjustment:

    • Evaluate response after 4-6 weeks
    • If inadequate response:
      • Consider increasing SSRI/SNRI dose
      • Intensify CBT
      • Consider alternative or augmentation strategies
  3. Maintenance Phase:

    • Continue effective medication for 6-12 months after symptom remission
    • Continue CBT techniques as needed
    • Gradually taper medication when discontinuing

Special Populations

  • Young individuals (7-17 years):

    • SSRIs are recommended as first-line treatment
    • Monitor closely for suicidal ideation 1
    • Parents/guardians with anxiety may benefit from psychoeducation and support 3
  • Elderly patients:

    • Start on lower medication doses and titrate more slowly
    • Consider potential drug interactions and side effects 1
  • Pregnant/lactating patients:

    • Use SSRIs with caution when benefits outweigh risks 1

Lifestyle Modifications

Recommend the following evidence-based lifestyle changes:

  • Establish consistent morning routine
  • Regular exercise
  • Good sleep hygiene
  • Limited screen time before bed and after waking
  • Spending time in nature
  • Practicing mindfulness and meditation 1

Important Cautions

  • Benzodiazepines (e.g., alprazolam):

    • Not recommended for routine use despite their effectiveness 1, 4
    • Risk of dependence with prolonged use 5
    • If used, should be short-term with careful monitoring
    • Dosage should be individualized and reduced gradually when discontinuing 5
  • Treatment Resistance:

    • Reevaluate diagnosis and medication adherence
    • Consider comorbidities that may require additional targeted interventions
    • Assess for substance use that may interfere with treatment 1

By following this evidence-based approach combining psychotherapy and appropriate pharmacotherapy, most patients with anxiety disorders can achieve significant symptom reduction and improved quality of life.

References

Guideline

Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of anxiety disorders.

Dialogues in clinical neuroscience, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.